|
 |
| gi/lower (stomach) |
|
Okawara, G., Winter, K., Donohue, J., Pisters, P., Crane, C., Greskovich, J., Anne, P. R., Bradley, J., Willet, C. and Ajani, J.: A Phase II Trial of Preoperative Chemotherapy and Chemoradiotherapy for Potentially Resectable Adenocarcinoma of the Stomach (RTOG 99-04). Proc Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, [23] (16S) pg. 312s, Abs. #4019, 2005. |
9904 |
chemo/surg |
 |
| gi/lower (stomach) |
|
Schwartz, G., Winter, K., Minsky, B., Janjan, N., Schaefer, P., Thomson, J., Anne, P. R., Gross, H., Willet, C. and Kelsen, D.: A Randomized Phase II Trial Comparing Two Paclitaxel (P)-Cisplatin (C) Containing Chemoradiation (CRT) Regimens as Adjuvant Therapy in Resected Gastric Cancer (RTOG Intergroup #0114). Proc Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, [23] (16S) pg. 312s, Abs. #4020, 2005. |
0114 |
chemo |
|
| gi/lower (colon) |
|
Martenson, J., Willett, C., Sargent, D., Mailliard, J., Donohue, J., Gunderson, L., Thomas Jr., C., Fisher, B., Benson, A., Myerson, R. and Goldberg, R.: A Phase III Study of Adjuvant Chemotherapy and Radiation Therapy Compared with Chemotherapy Alone in the Surgical Adjuvant Treatment of Colon Cancer: Results of Intergroup Protocol 0130. J Clin Oncol, 22 (16):3277-3283, 2004. |
9203 |
rt |
|
| gi/lower (rectal) |
|
Mohiuddin, M., Winter, K., Mitchell, E., Hanna, N., Yuen, A., Nicholas, C., Shane, R., Hayostek, C. and Willet, C.: Results of RTOG-0012 Randomized Phase II Study of Neoadjuvant Combined Modality Chemoradiation for Distal Rectal Cancer. Proc Amer Soc Thera Rad Onc (ASTRO), Atlanta, GA, Int J Radiat Oncol Biol Phys, [60] (1) pg. S138-139, Abs. #16, 2004. |
0012 |
chemo/rt |
|
| gi/upper |
8501, 9207, 9405 |
Thomas Jr., C., Berkey, B., Minsky, B., Gaspar, L., Herskovic , A., Rich, T. and Gunderson, L.: Recursive Partitioning Analysis of Pretreatment Variables of 416 Patients with Locoregional Esophageal Cancer Treated with Definitive Concomitant Chemoradiotherapy on Intergroup and Radiation Therapy Oncology Group Trials. Int J Radiat Onco Biol Phys, 58 (5):1405-1410, 2004. |
9405, 9207, 8501 |
gi/upper
(rt/dose) |
|
| gi/lower |
9812 |
Rich, T., Harris, J., Abrams, R. A., Erickson, B., Doherty, M., Paradelo, J., Small Jr, W., Safran, H. and Wanebo, H.: Phase II Study of External Irradiation and Weekly Paclitaxel for Nonmetastatic, Unresectable Pancreatic Cancer: RTOG-98-12. Am J Clin Oncol, 27 (1):51-56, 2004. |
9812 |
gi/lower (pancreatis)
chemo |
|
| gi/lower |
|
Mitchell, E., Winter, K., Mohiuddin, M., Hanna, N., Yuen, A., Nicholas, C., Share, R., Hayostek, C. and Willet, C.: Randomized Phase II Trial of Preoperative Combined Modality Chemoradiation For Distal Rectal Cancer. Proc Am Soc Clin Oncol (ASCO), New Orleans, LA, J Clin Oncol, [23] (June 5-8, 2004) pg. 254, Abs. #3535, 2004. |
0012 |
gi/lower
chemo/rt |
|
| gi/upper |
9003, 9405 |
Movsas, B., Scott, C. and Bruner, D.: Pre-Treatment Factors Significantly Influence Quality Of Life In Cancer Patients: A Radiation Therapy Oncology Group (RTOG) Analysis. Proceeding from Int Soc Qual of Life Research (ISOQOL), Orlando, FL, Quality of Life Research, pg. 623, Abs. #9, 2002. |
9003,9405, 8901,9401,9020 |
multi-sites
QOL |
|
| gi/upper |
8501, 9207, 9405 |
Thomas Jr., C., Berkey, B., Minsky, B., Gaspar, L., Herskovic , A., Rich, T. and Gunderson, L.: Recursive Partitioning Analysis (RPA) Of Pre-Treatment Variables For 416 Patients With Loco-Regional Esophageal Cancer Treated With Concomitant Chemoradiotherapy (CT-RT) On Intergroup And Radiation Therapy Oncology Group (RTOG) Trials. Proc Am Soc Thera Rad Oncol (ASTRO), New Orleans, LA, Int J Radiat Oncol Biol Phys, [54] (2) pg. 131, Abs. #221, 2002. |
9405,9207,8501 |
gi/upper
other(rt/dose) |
|
| gi/lower |
|
Smalley, S., Benedetti, J., Williamson, S., Robertson, J., Fisher, B., Martenson, J., Benson, A., Mayer, R., Cripps, C. and Macdonald, J.: Intergroup 0144 - Phase III Trial of 5-FU Based Chemotherapy Regimens Plus Radiotherapy (XRT) in Postoperative Adjuvant Rectal Cancer. Bolus 5-FU vs Prolonged Venous Infusion (PVI) Before and After XRT + PVI vs Bolus 5-FU + Leucovorin (LV) + Levamisole (LEV) Before and After XRT + Bolus 5-FU + LV. Proceeding from Am Soc Clin Oncol (ASCO), Chicago, IL, J Clin Oncol, [22] (May 31-June 3, 2003) pg. 251, Abs. #1006, 2003. |
9403 |
gi/lower(rectal)
surg |
|
| gi/upper |
|
Ding, I., Xu, J., Liu, W. and Okunieff, P.: Therapeutic Potential of Curcumin in Human Esophageal Cancers. ASCO Molecular Therapeutics Symposium, San Diego, CA, ASCO Molecular Booklet, (November, 2002) pg. Abs. #oral-pres., 2002. |
|
curcumin sens |
|
| gi/upper |
|
Poon, I., Xia, P., Sultanem, K., Quivey, J., Weinberg, V., Akazawa, C., Verhey, L., Akazawa, C. and Lee, N.: A Dose Volume Histogram Comparison of Inverse Planned and Forward Planned IMRT in Nasopharyngeal Carcinoma. RTOG Semi-Annual Meeting, Philadelphia, PA, RTOG New Investigator Award, pg. 1, Abs. #1, 2002. |
|
rt |
|
| gi/upper |
|
Elsaleh, H.: Unmasking the Influence of Molecular Heterogeneity in Determining Outcomes from Chemotherapy in Gastrointestinal Cancer. RTOG Semi-Annual Meeting, Houston, TX, RTOG New Investigator Award, pg. 1, Abs. #1, 2003. |
|
molecular markers chemo |
|
| gi/upper |
9207 |
Gaspar, L., Winter, K., Kocha, W., Pinover, W., Herskovic, A., Graham, M. and Gunderson, L.: Swallowing Function and Weight Change Observed in a Phase I/II Study of External Beam Radiation, Brachytherapy and Concurrent Chemotherapy in Localized Cancer of the Esophagus (RTOG 9207). Cancer J, 7 (5):369-371, 2001. |
9207 |
brachy |
|
| gi/upper |
8501, 9207, 9405 |
Thomas Jr., C., Berkey, B., Minsky, B., Gaspar, L., Herskovic , A., Rich, T. and Gunderson, L.: Recursive Partitioning Analysis (RPA) Of Pre-Treatment Variables For 416 Patients With Loco-Regional Esophageal Cancer Treated With Concomitant Chemoradiotherapy (CT-RT) On Intergroup And Radiation Therapy Oncology Group (RTOG) Trials. Proc Am Soc Thera Rad Oncol (ASTRO), New Orleans, LA, Int J Radiat Oncol Biol Phys, [54] (2) pg. 131, Abs. #221, 2002. |
9405,9207,8501 |
other (rt/dose) |
|
| gi/lower |
|
Colorectal Cancer Collaborative Group: Adjuvant Radiotherpay for Rectal Cancer: A systematic Overview of 85-07 Patients from 22 Randomised Trials. The Lancet, 358 1291-1304, 2001. |
8507 |
stat/meth |
|
| gi/lower |
|
Tepper, J., O'Connell, M., Niedzwiecki, D., Hollis, D., Compton, C., Benson III, A., Cummings, B., Gunderson, L., Macdonald, J. and Mayer, R.: Impact of Number of Nodes Retrieved on Outcome in Patients with Rectal Cancer. J Clin Oncol, 19 (1):157-163, 2001. |
9014 |
chemo |
|
| gi/lower |
|
Tepper, J., M, O. C., Niedzwiecki, D., Hollis, D., Benson III, A., Cummings, B., Gunderson, L., Macdonald, J., Martenson, J. and Mayer, R.: Adjuvant Therapy in Rectal Cancer: Analysis of Stage, Sex and Local Control-Final Report of Intergroup 0114. J Clin Oncol, 20 (7):1744-50, 2002. |
9014 |
chemo |
|
| gi/lower |
|
Miller, R., Sargent, D., Martenson, J., Haller, D., Mayer, R., Gunderson, L., Rich, T., Cha, S. and O'Connell, M.: Acute Diarrhea During Adjuvant Therapy for Rectal Cancer: A Detailed Analysis from a Randomized Intergroup Trial. Int J Radiat Onco Biol Phys, 54 (2):409-413, 2002. |
9014 |
chemo |
|
| gi/lower |
|
Gunderson, L., Sargent, D., Tepper, J., O'Connell, M., Allmer, C., Smalley, S., Martenson, J., Haller, D., Mayer, R., Rich, T., Ajani, J., Macdonald, J. and Goldberg, R.: Impact of T and N Substage on Survival and Disease Relapse in Adjuvant Rectal Cancer: A Pooled Analysis. Int J Radiat Onco Biol Phys, 54 (2):386-396, 2002. |
9014 |
chemo |
|
| gi/upper |
9405 |
Minsky, B., Pajak, T., Ginsberg, R., Pisansky, T., Martenson, J., Komaki, R., Okawara, G., Rosenthal, S. and Kelsen, D.: INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy. J Clin Oncol, 20 (5):1167-1174, 2002. |
9405 |
other (rt/dose) |
|
| gi/lower |
|
Smalley, S., Gunderson, L., Tepper, J., Martenson, J., Minsky, B., Willet, C. and Rich, T.: Gastric Surgical Adjuvant Radiotherapy Consensus Report: Rationale and Treatment Implementation. Int J Radiat Onco Biol Phys, 52 (2):283-293, 2002. |
|
surg |
|
| gi/upper |
|
Macdonald, J., Smalley, S., Benedetti, J., Hundahl, S., Estes, N., Stemmermann, G., Haller, D., Ajani, J., Gunderson, L., Jessup, M. and Martenson, J.: Chemoradiotherapy After Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction. New Eng J Med, 345(10):725-730, 2001. |
9018 |
surg |
|
| gi/upper |
9405 |
Kachnic, L., Scott, C., Ginsberg, R., Pisansky, T., Martenson, J., Komaki, R., Okawara, G., Rosenthal, S., Kelsen, D. and Minsky, B.: One Year Follow-Up Reveals No Difference In Quality of Life Between High Dose And Conventional Dose Radiation: A Quality of Life Assessment of RTOG 94-05. Proc of Am Soc Ther Rad Oncol (ASTRO), San Francisco, CA, Int J Radiat Oncol Biol Phys, 51(3, Suppl 1): pg. 97, Abs. #172, 2001. |
9405 |
QOL |
|
| gi/lower |
9812 |
Rich, T., Harris, J., Abrams, R. A., Erickson, B., Doherty, M., Paradelo, J., Small Jr, W., Safran, H. and Wanebo, H.: A Phase II Study of External Irradiation And Weekly Paclitaxel for Non-Metastatic, Unresectable Pancreatic Cancer: A Preliminary Report of RTOG Protocol 98-12. Proc of Am Soc Ther Rad Oncol (ASTRO), San Francisco, CA, Int J Radiat Oncol Biol Phys, 51(3, Suppl 1): pg. 29-30, Abs. #46, 2001. |
9812 |
chemo |
|
| gi/lower |
|
Merati, K., Siadaty, M., Andea, A., Sarkar, F., Ben-Josef, E., Mohammad, R., Philip, P., Shields, A., Vaitkevicius, V., Grignon, D. and Adsay, N.: Expression of Inflammatory Modulator COX-2 in Pancreatic Ductal Adenocarcinoma and its Relationship to Pathologic and Clinical Parameters. Am J Clin Oncol (CCT), 24(5):447-452, 2001. |
----- |
path |
|
| gi/lower |
|
Stocchi, L., Nelson, H., Sargent, D., O'Connell, M., Tepper, J. E., Krook, J., Beart Jr, R. and NCCTG: Impact of Surgical and Pathologic Variables in Rectal Cancer: A United States Community and Cooperative Group Report. J Clin Oncol, 19(18):3895-3902, 2001. |
9203 |
surg/path |
|
| gi/lower |
|
Tepper, J., O’Connell, M., Niedzwiecki, D., Macdonald, J. and Martenson, J.: Final Report of INT 0114 – Adjuvant Therapy in Rectal Cancer: Analysis by Treatment, Stage and Gender. Proceeding from Am Soc Clin Oncol (ASCO), San Francisco, CA, J Clin Oncol, 20 #489, 123a, 2001. |
9014 |
|
|
| gi/upper |
9207 |
Gaspar, L. E., Winter, K., Kocha, W. I., Coia, L. R., Herskovic, A. and Graham, M.: A Phase I/II Study of External Beam Radiation, Brachytherapy and Concurrent Chemotherapy for Patients with Localized Carcinoma of the Esophagus (RTOG 9207) Final Report. Cancer, 88(5):988-995, 2000. |
9207 |
Brachy |
|
| gi/upper |
9207 |
Gaspar, L., Winter, K., Kocha, W., Pinover, W., Herskovic, A., Graham, M. and Gunderson, L.: Swallowing Function and Weight Change Observed in a Phase I/II Study of External Beam Radiation, Brachytherapy and Concurrent Chemotherapy in Localized Cancer of the Esophagus (RTOG 9207). American Radium Society, London, England, American Radium Society Proceedings, [April 1-5, 2000], pg. 16, Abs. #8, 2000. |
9207 |
Brachy |
|
| gi/upper |
9405 |
Minsky, B., Berkey, B., Kelsen, D., Ginsberg, R., Pisansky, T., Martenson, J., Komaki, R., Okawara, G. and Rosenthal, S.: Preliminary Results of Intergroup INT 0123 Randomized Trial of Combined Modality Therapy (CMT) for Esophageal Cancer: Conventional vs. High Dose Radiation Therapy. Proc of Am Soc Clin Oncol (ASCO), New Orleans, LA, J Clin Oncol, [19], pg. 239a, Abs. #927, 2000. |
9405 |
other (rt/dose) |
|
| gi/upper |
|
Macdonald, J., Smalley, S., Benedetti, J., Estes, N., Haller, D., Ajani, J., Gunderson, L., Jessup, M. and Martenson, J.: Postoperative Combined Radiation and Chemotherapy Improves Disease-Free Survival (DFS) and Overall Survival (OS) in Resected Adenocarcinoma of the Stomach and GE Junction. Results of Intergroup Study INT-0116 (SWOG 9008). Proc of Am Soc Clin Oncol (ASCO), New Orleans, LA, J Clin Oncol, [19], pg. 1a, Abs. #1, 2000. (RTOG/SWOG/CALGB/ECOG/NCCTG) |
9018 |
surg |
|
| gi/lower |
|
Russell, A., Harris, J., Rosenberg, P., Sause, W., Fisher, B., Hoffman, J., Kraybill, W. and Byhardt, R.: Anal Sphincter Conservation for Patients with Adenocarcinoma of the Distal Rectum: Long-Term Results of Radiation Therapy Oncology Group Protocol 89-02. Int J Radiat Oncol Biol Phys, 46(2):313-322, 2000. |
8902 |
rt/ct/chemo |
|
| gi/lower |
|
Epstein, B., Pajak, T., Haulk, T., Herpst, J., Order, S. and Abrams, R.: Metastatic Non-Resectable Fibrolamellar Hepatoma: Prognostic Features & Natural History. Am J Clin Oncol, 22(1):22-28, 1999. |
8301 |
BRM |
|
| gi/lower |
|
Martenson, J., Willett, C., Sargent, D., Donohue, J., Goldberg, R., Wasserman, T., Gunderson, L., Myerson, R., Thomas, P., Fisher, B. and Benson, A.: A Phase III Study of Adjuvant Radiation Therapy (RT), 5-Flouorouraoil (5-FU), and Levamisole (LEV) vs 5-FU andLEV in Selected Patients with Resected High Risk Colon Cancer: Initial Results of INT 0130. Proc of Am Soc Clin Oncol (ASCO), Atlanta, GA, J Clin Oncol, [18], pg. 235a, Abs. #904, 1999. |
9203 |
rt |
|
| gi/lower |
|
Steele, G., Herndon, J., Bleday, R., Russell, A., Benson, A., Hussain, M., Burgess, A., Tepper, J. and Mayer, R.: Sphincter-Sparing Treatment for Distal Rectal Adenocarcinoma. Ann Surg Oncol, July-Aug: 6(5):433-441, 1999. |
9109 |
td/surg |
|
| gi/upper |
8501 |
Streeter, O., Martz, K., Gaspar, L., DelRowe, J., Asbell, S., Salter, M. and Roach, M.: Does Race Influcence Survival for Esophageal Cancer Patients Treated on the Radiation and Chemotherapy Arm of RTOG 85-01? Int J Radiat Oncol Biol Phys, 44(5):1047-1052, 1999. |
8501 |
specpop |
|
| gi/lower |
|
Bonin, S., Pajak, T., Russell, A., Coia, L., Paris, K., Flam, M. and Sauter, S.: Overexperssion of p53 Protein and Outcome of Patients Treated with Cheomradiation
for Carcinoma of the Anal Canal. Cancer, 85(6): 1226-1233, 1999. |
8704 |
path/horm |
|
| gi/upper |
|
Sheahan, D., Guo, M., Kelsen, D., Estes, N., Haller, D., Mortimer, J., Kocha, W. and Young, J.: Extranodal Extension (ENE) in Esophageal Cancer--A Significant Porgnostic Factor: National Intergroup Study INT 0113/RTOG 89-11. US Canadian Acad of Pathology, Modern Path, [12], pg. 84A, Abs. #482, 1999. |
8911 |
path |
|
| gi/upper |
|
Minsky, B. D., Neuberg, D., Kelsen, D. P., Pisansky, T. M., Ginsberg, R., Pajak, T. F., Salter, M. and Benson III, A.: Final Report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II Trial of Neoadjuvant Chemotherapy plus Concurrent Chemotherapy and High Dose Radiation for Squamous Cell Carcinoma of the Esophagus. Int J Radiat Oncol Biol Phys, 43(3):517-523, 1999. |
9012 |
chemo/surg |
|
| gi/upper |
8501 |
Cooper, J., Guo, M., Herskovic, A., Macdonald, J., Al-Sarraf, M., Byhardt, R., Russell, A., Beitler, J., Meredith, R., Asbell, S., Grahman, M. and Leichman, L.: Chemoradiotherapy Significantly Improves the Cure Rate of Locally Advanced Esophageal Cancer Long-Term Follow-Up of a Prospective Randomized Intergroup Trial (RTOG 85-01). J Amer Med Assoc (JAMA), 281(17):1623-1627, 1999. |
8501 |
chemo |
|
| gi/lower |
|
Epstein, B., Pajak, T., Haulk, T., Herpst, J., Order, S. and Abrams, R.: Metastatic Non-Resectable Fibrolamellar Hepatoma: Prognostic Features & Natural History. Am J Clin Oncol, 22(1):22-28, 1999. |
8301 |
BRM |
|
| gi/lower |
|
Flam, M., Pajak, T., Haller, D., Myerson, R., Russell, A., Pinover, W., Cooper, J., Thompson, J. and John, M.: The Role of Mitomycin in Combination with 5-Fluorouracil and Radiotherapy in the Definitive Nonsurgical Treatment of Edipermoid Carcinoma of the Anal Canal: 5 Year Updated Results of a Phase III Randomized Intergroup Study RTOG 8704/ECOG 1289. American Radium Society, Hapuna Beach, Hawaii, ARS Meeting Book, pg. Abs. 1999. |
8704 |
chemo |
|
| gi/lower |
|
Martenson, J., Willett, C., Sargent, D., Donohue, J., Goldberg, R., Wasserman, T., Gunderson, L., Myerson, R., Thomas, P., Fisher, B. and Benson, A.: A Phase III Study of Adjuvant Radiation Therapy (RT), 5-Flouorouraoil (5-FU), and Levamisole (LEV) vs 5-FU andLEV in Selected Patients with Resected High Risk Colon Cancer: Initial Results of INT 0130. Proc of Am Soc Clin Oncol (ASCO), Atlanta, GA, J Clin Oncol, [18], pg. 235a, Abs. #904, 1999. |
9203 |
rt |
|
| gi/lower |
|
Flam, M. S., Pajak, T. F., Haller, D., Myerson, R., Russell, A., Pinover, W., Cooper, J., Thompson, J. and John, M.: The Role of Mitomycin in Combination with 5-Fluorouracil and Radiotherapy in the Definitive Nonsurgical Treatment of Epidermoid Carcinoma of the Anal Canal: 5 Year Updated Results of a Phase III Randomized Study (RTOG 8704/ECOG 1289). Japan/US Cancer Therapy Symposium, Hirsohima, Japan, pg. Abs. 1999. |
8704 |
chemo |
|
| gi/upper |
|
Kelsen, D., Ginsberg, R., Pajak, T., Gunderson, L., Mortimer, J., Estes, N., Haller, D., Ajani, J., Kocha, W., Minsky, B. and Roth, J.: Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal Cancer. New Eng J Med, 339(27):1979-1984, 1998. |
|
surg |
|
| gi/lower |
|
Russell, A., Pajak, T., Rosenberg, P., Sause, W., Pinover, W., Fisher, B., Kraybill, B. and Byhardt, R.: Anal Sphincter Conservation for Patients with Adenocarcinoma of the Distal Rectum: Long Term Results of a Clinical Cooperative Group Protocol RTOG 8902. Proc Am Soc Thera Rad Oncol (ASTRO), Phoenix, AZ, Int J Radiat Oncol Biol Phys, [42], pg. 162, Abs. #76, 1998. |
|
rt, ct, surg |
|
| gi/upper |
|
John, M., Flam, M., Berkey, B., Johnson, D., Wasserman, T., Russell, A., Fu, K., Hanks, G., Cooper, J. and Rotman, M.: 5 Year Results and Analyses of a Phase III Randomized RTOG/ECOG Chemoradiation Protocol for Anal Cancer. Proc of Am Soc Clin Oncol (ASCO), Los Angeles, CA, J Clin Oncol, [17], pg. 258a, Abs. #989, 1998. |
|
chemo |
|
| gi/upper |
|
Gaspar, L. E., Winter, K., Kocha, W. I., Coia, L. R., Herskovic, A. and Graham, M.: A Phase I/II Study of External Beam Radiation, Brachytherapy and Concurrent Chemotherapy in Localized Cancer of the Esophagus (RTOG 92-07): Final Report. Am Radium Soc (ARS), Monte Carlo, Monaco, Proceedings Amer Rad Soc, [May 2-6], pg. 52-53, Abs. #59, 1998. |
|
brachy |
|
| gi/lower |
|
Conference Proceedings 2473 John, M., Flam, M., Berkey, B., Johnson, D., Wasserman, T., Russell, A., Fu, K., Hanks, G., Cooper, J. and Rotman, M.: 5 Year Results and Analyses of a Phase III Randomized RTOG/ECOG Chemoradiation Protocol for Anal Cancer. Proc of Am Soc Clin Oncol (ASCO), Los Angeles, CA, J Clin Oncol, [17], pg. 258a, Abs. #989, 1998.
| |
chemo |
|
| gi/lower |
|
John, M., Pajak, T., Kreig, R., Pinover, W. and Myerson, R.: Dose Escalation Without Split-Course Chemoradiation for Anal Cancer: Results of a Phase II RTOG Study. Proc Am Soc Thera Rad Oncol (ASTRO), Orlando, FL, Int J Radiat Oncol Biol Phys, [39], pg. 203, Abs. #136, 1997. |
|
td/surg/chemo |
|
| gi/lower |
|
Steele, J., Herndon, J., Burgess, A., Bleday, R., Russell, A., Benson, A., Hussain, M. and Mayer, R.: Sphincter Sparing Treatment for Distal Rectal Adenocarcinoma: A Phase II Intergroup Study. Proc of Am Soc Clin Oncol (ASCO), Denver, CO, [16], pg. 256a, Abs. #908, 1997. |
|
td/surg |
|
| gi/upper |
|
Kelsen, D., Ginsberg, R., Qian, C., Gunderson, L., Mortimer, J., Estes, N., Haller, D., Ajani, J., Kocha, W., Roth, J. and Minsky, B.: Chemotherapy Followed by Operation versus Operation Alone in the Treatment of Patients with Localized Esophageal Cancer: A Preliminary Report on Intergroup Study 113 (RTOG 89-11). Proceedings of Proc of Am Soc Clin Oncol (ASCO), J Clin Oncol 16 :276a, 1997. |
89-11 |
surg |
|
| gi/upper |
|
Gaspar, L.E., Qian, C., Kocha, W.I., Coia, L.R., Herskovic, A. and Graham, M.: A Phase I/II Study of External Beam Radiation, Brachytherapy and Concurrent Chemotherapy in Localized Cancer of the Esophagus (RTOG 92-07): Preliminary Toxicity Report. Int J Radiat Oncol Biol Phys 37 (3):593-599, 1997. |
92-07 |
brachy/chemo/td |
|
| gi/gu/gyn |
|
Halberg, F. E., Cosmatos, D., Gunderson, L. L., Noyes, R. D., Hanks, G. R., Buswell, L., Nagorney, D. and Coleman, C. N.: RTOG 89-06: A Phase I Study to Evaluate Intraoperative Radiation Therapy and the Hypoxic Cell Sensitizer Etanidazole in Locally Advanced Malignancies. Int J Radiat Oncol Biol Phys, 28(1):201-206, 1994. |
8906 |
IORT/sens/surg |
|
| gi/gyn |
|
Halberg, F., Cosmatos, D., Gunderson, L., Noyes, D., Hanks, G. and Coleman, C.: A Phase I Pilot Study to Evaluate Intraoperative Radiation Therapy (IORT) and the Hypoxic Cell Sensitizer Etanidazole in Patients with Locally Advanced Malignancies (RTOG protocol 89-06). Proc Am Soc Thera Radiol Oncol (ASTRO), San Diego, Int J Radiat Oncol Biol Phys, 24 (1):170, [78], 1992. |
8906 |
IORT/sens/surg |
|
| gi/lower |
|
Avizonis, V. N., Buzydlowski, J., Lanciano, R., Owens, J. R., Noyes, R. D. and Hanks, G. E.: Treatment of Adenocarcinoma of the Stomach with Resection, Intraoperative Radiotherapy and Adjuvant External Beam Radiation: A Phase II Study from Radiation Therapy Oncology Group 85-04. Ann Surg Oncol, 2(4):295-302, 1995. |
8504 |
surg/IORT |
|
| gi/lower |
|
Sause, W., Pajak, T., Noyes, D., Dobelbower, R., Fischbach, J., Doggett, S. and Mohiuddin, M.: Evaluation of Preoperative Radiation Therapy in Operable Colorectal Cancer. Ann Surg, 220(No. 5 (November)):668-675, 1994. |
8115 |
surg |
|
| gi/lower |
|
Flam, M., John, M., Peters, T., Hoffman, J., Savage, D., Petrelli, N., Myerson, R., Rotman, M., Mesic, J., Swift, P., Coia, L., Cooper, J. and Gunderson, L.: Radiation and 5-Fluorouracil (5FU) vs Radiation, 5FU, Mitomycin-C (MMC) in the Treatment of Anal Canal Carcinoma: Preliminary Results of a Phase III Randomized RTOG/ECOG Intergroup Trial. Proc Am Soc Clin Oncol (ASCO), Orlando, FL, Am J Clin Oncol (CCT), 12 192, [557], 1993. |
8704 |
chemo/surg |
|
| gi/lower |
|
Epstein, B., Pajak, T., Haulk, T. and Order, S.: Fibrolamellar Hepatoma: Comparison of Prognostic Features and Outcome with Matched Typical Histology Hepatoma Patients from the Radiation Therapy Oncology Group (RTOG) Database. Radiological Society of North America, Radiology, 185 218, [685], 1992. |
8301 |
path |
|
| gi/lower |
|
Komaki, R., Wadler, S., Peters, T., Byhardt, R., Order, S., Gallagher, M., Herskovic, A. and Pedersen, J.: High Dose Local Irradiation plus Prophylactic Hepatic Irradiation and Chemotherapy for Inoperable Adenocarcinoma of the Pancreas. A Preliminary Report of a Multi-Institutional Trial (Radiation Therapy Oncology Group Protocol 88-01). Cancer, 69(11):2807-2812, 1992. |
8801 |
chemo/td |
|
| gi/lower |
|
Komaki, R., Wadler, S., Peters, T., Byhardt, R., Order, S., Gallagher, M., Herskovic, A. and Pedersen, J.: High Dose Local Plus Prophylactic Hepatic Irradiation (PHI) and Chemotherapy for Inoperable Adenocarcinoma of Pancreas: Preliminary Report of Multi-Institutional Trial (RTOG 88-01). Proc American Radium Society, Montreal, 16, [36], 1991. |
8801 |
chemo/td |
|
| gi/lower |
|
John, M., Pajak, T., Flam, M., Hoffman, J., Markoe, A., Wolkov, H. and Paris, K.: Dose Acceleration in Chemoradiation (CRX) for Anal Cancer: Preliminary Results of RTOG 92-08. Proc Am Soc Thera Radiol Oncol (ASTRO), Miami Beach, FL, Int J Radiat Oncol Biol Phys, 32 (Supplement 1):157, [33], 1995. |
9208 |
chemo/td |
|
| gi/lower |
|
John, M., Flam, M., Pajak, T., Hoffman, J., Savage, D., Petrelli, N., Myerson, R., Rotman, M., Mesic, J., Swift, P., Coia, L., Cooper, J. and Gunderson, L.: Is Mitomycin-C Necessary in the Chemoradiation Regimen for Anal Canal Carcinoma? Interim Results of a Phase III Randomized Intergroup Study. Proc Am Soc Thera Radiol Oncol (ASTRO), New Orleans, LA, Int J Radiat Oncol Biol Phys, 27 245, [191], 1993. |
8704 |
chemo |
|
| gi/lower |
|
Flam, M. S., John, M. J., Pajak, T. F., Petrelli, N., Myerson, R., Doggett, S., Quivey, J., Rotman, M., Kerman, H., Coia, L. and Murray, K.: Role of Mitomycin in Combination with Fluorouracil and Radiotherapy, and of Salvage Chemoradiation in the Definitive Nonsurgical Treatment of Epidermoid Carcinoma of the Anal Canal: Results of a Phase III Randomized Intergroup Study. J Clin Oncol, 14(9):2527-2539, 1996. |
8704 |
chemo |
|
| gi/lower |
|
Flam, M., John, M., Pajak, T., Petrelli, N., Myerson, R., Doggett, S., Rotman, M., Quivey, J., Kerman, H., Coia, L., Murray, K., Hoffman, J. and Conner, N.: Radiation (RT) and 5 Fluorouracil (5FU) vs. Radiation, F5U Mitomycin-C (MMC) in the Treatment of Anal Carcinoma: Results of a Phase III Randomized RTOG/ECOG Intergroup. Proc Am Soc Clin Oncol (ASCO), Los Angeles, CA, Proc Am Soc Clin Oncol, 14 (March 1995):191, [443*], 1995. |
8704 |
chemo |
|
| gi/lower |
|
Stillwagon, G., Order, S., Guse, C., Leibel, S., Asbell, S., Klein, J. and Leichner, P.: Prognostic Factors in Unresectable Hepatocellular Cancer: Radiation Therapy Oncology Group (RTOG) Study 83-01. Int J Radiat Oncol Biol Phys, 20:65-71, 1991. |
8301 |
radiopharm |
|
| gi/lower |
|
John, M., Pajak, T., Flam, M., Hoffman, J., Markoe, A., Wolkov, H. and Paris, K.: Dose Escalation in Chemoradiation for Anal Cancer: Preliminary Results of RTOG 92-08. The Cancer Journal from Scientific American, 2(4):205-211, 1996. |
9208 |
chemo |
|
| gi/lower |
|
Wolkov, H., Graves, G., Won, M., Sause, W., Byhardt, R. and Hanks, G.: Intraoperative Radiation Therapy of Extrahepatic Biliary Carcinoma: A Report of RTOG 85-06. Am J Clin Oncol (CCT), 15(4):323-327, 1992. |
8506 |
IORT/surg |
|
| gi/lower |
|
Russell, A., Clyde, C., Wasserman, T., Turner, S. and Rotman, M.: Accelerated Hyperfractionated Hepatic Irradiation in the Management of Patients with Liver Metastases. Results of the RTOG Dose Escalating Protocol. Int J Radiat Oncol Biol Phys, 27(1):117-123, 1993. |
8405 |
td |
|
| gi/lower |
|
Sause, W., Pajak, T., Noyes, D., Dobelbower, R., Fischbach, J., Doggett, S. and Mohiuddin, M.: RTOG 81-15 ECOG 83-23 Evaluation of Preoperative Radiation Therapy in Operable Rectal Carcinoma. Proc Am Soc Thera Radiol Oncol (ASTRO), New Orleans, LA, Int J Radiat Oncol Biol Phys, 27 171, [72], 1993. |
8115 |
td/surg |
|
| gi/lower |
|
Russell, A., Clyde, C., Wasserman, T., Turner, S. and Rotman, M.: Accelerated Hyperfractionated Hepatic Irradiation in the Management of Patients with Liver Metastasis. Final results of the RTOG Dose Escalating Protocol. Proc Am Soc Thera Radiol Oncol (ASTRO), San Diego, Int J Radiat Oncol Biol Phys, 24 (1):215, [152], 1992. |
8405 |
td |
|
| gi/lower |
|
Bonin, S., Qian, C., Russell, A., Coia, L., Paris, K., Flam, M. and Sauter, E.: Overexpression of p53 Protein is Associated with Decreased Local Disease-Free Survival in Patients Treated with Chemoradiation for Anal Canal Cancer: A Report of RTOG 87-04. Proc Am Soc Thera Radiol Oncol (ASTRO), Los Angeles, CA, Int J Radiat Oncol Biol Phys, 36 (1):210, [104], 1996. |
8704 |
path/chemo |
|
| gi/lower |
|
O'Connell, M., Martenson, J., Wieand, H., Krook, J., Macdonald, J., Haller, D., Mayer, R., Gunderson, L. and Rich, T.: Improving Adjuvant Therapy for Rectal Cancer by Combining Protracted-Infusion Fluorouracil with Radiation Therapy after Curative Surgery. New Eng J Med, 331(8):502-507, 1994. |
8811 |
chemo/surg |
|
| gi/lower |
|
Rich, T., O'Connell, M., Martenson, J., Wieand, H., Krook, J., Macdonald, J., Haller, D., Mayer, R. and Gunderson, L.: Improved Therapeutic Ratio with Protracted Venous Infusion (PVI) 5-Fluorouracil (5FU) During Postoperative External Beam Radiotherapy for High-Risk Rectal Cancer. Proc Am Soc Thera Radiol Oncol (ASTRO), New Orleans, LA, Int J Radiat Oncol Biol Phys, 27 (S1):245-246, [192], 1993. |
8811 |
chemo |
|
| gi/lower |
|
O'Connell, M., Wiend, H., Krook, J., Martenson, J., Macdonald, J., Rich, T., Haller, D., Mayer, R. and Gunderson, L.: Lack of Value for Methyl-ccnu (MeCCNU) as a Component of Effective Rectal Cancer Surgical Adjuvant Therapy, Interim Analysis of Intergroup Protocol 86-47-51. Proc Am Soc Clin Oncol (ASCO), 10 134, [403], 1991. |
8811 |
chemo/surg |
|
| gi/lower |
|
Noyes, R., Pajak, T., Sause, W., Dobelbower, R., Fishcbach, J., Doggett, S. and Mohiuddin, M.: Evaluation of Preoperative Radiation Therapy in Rectal Carcinoma. Intergroup study: RTOG 81-15, ECOG 83-23. 47th Annual Cancer Symposium, Houston, TX, 114, [113], 1994. |
8115 |
surg |
|
| gi/lower |
|
Tepper, J., Noyes, D., Krall, J., Sause, W., Wolkov, H., Dobelbower, R., Thomson, J., Owens, J. and Hanks, G.: Intraoperative Radiation Therapy of Pancreatic Carcinoma: A Report of RTOG 85-05. Int J Radiat Oncol Biol Phys, 21:1145-1149, 1991. |
8505 |
IORT/surg |
|
| gi/lower |
|
Coia, L. R., Myerson, R. J. and Tepper, J. E.: Late Effects of Radiation Therapy on the Gastrointestinal Tract. Int J Radiat Oncol Biol Phys, 31(5):1213-1236, 1995. |
|
lateff |
|
| gi/lower |
|
Lanciano, R. M., Calkins, A. R., Wolkov, H. B., Buzydlowski, J., Noyes, R. D., Sause, W., Nelson, D., Willett, C., Owens, J. C. and Hanks, G. E.: A Phase I/II Study of Intraoperative Radiotherapy in Advanced Unresectable or Recurrent Carcinoma of the Rectum: A Radiation Therapy Oncology Group (RTOG) Study. J Surg Oncol, 53(1):20-29, 1993. |
8508 |
IORT/surg |
|
| gi/lower |
|
Hanks, G., Owens, J., Won, M., Noyes, D., Sause, W. and Lanciano, R.: Outcome of Gastric Cancer Treated with Surgery, Intraoperative Electron Beam Radiation and Post-op External Beam Irradiation in RTOG 85-04. Proc American Radium Society, Montreal, 16, [40], 1991. |
8504 |
surg/IORT |
|
| gi/lower |
|
O'Connell, M., Martenson, J., Rich, T., Wieand, H., Krook, J., Macdonal, J., Haller, D., Mayer, R. and Gunderson, L.: Protracted Venous Infusion (PVI) 5-Fluorouracil (5FU) as a Component of Effective Combined Modality Postoperative Surgical Adjuvant Therapy for High-Risk Rectal Cancer. Proc Am Soc Thera Radiol Oncol (ASTRO), Orlando, FL, 12 193, [564], 1993. |
8811 |
chemo/surg |
|
| gi/lower |
|
Order, S., Pajak, T., Leibel, S., Asbell, S., Leichner, P., Ettinger, D., Stillwagon, G., Herpst, J., Haulk, T., Kopher, K., Frazier, C. and Klein, J.: A Randomized Prospective Trial Comparing Full Dose Chemotherapy to 131I Anti-Ferritin: An RTOG Study. Int J Radiat Oncol Biol Phys, 20:953-963, 1991. |
8319 |
radiopharm |
|
gi/lower
/gu/gyn |
|
Spanos, W., Marcus, S., Perez, C., Grigsby, P., Doggett, R., Steinfeld, A. and Poulter, C.: Effect of Rest Interval Change on Tumor and Normal Tissue Response: Report of Phase 3 Study of Accelerated Split Course Palliative Radiation of Advanced Pelvic Malignancies (RTOG 85-02). Proc American Radium Society, 16-17, [42], 1991. |
8502 |
td |
|
| gi/lower/gyn |
|
Coleman, C., Noll, L., Riese, N., Buswell, L., Howes, A., Loeffler, J., Alexander, E., Wen, P., Harris, J., Kramer, R., Hurwitz, S., Neben, T. and Grigsby, P.: Final Report of the Phase I Trial of Continuous Infusion Etanidazole (SR 2508): A Radiation Therapy Oncology Group Study. Int J Radiat Oncol Biol Phys, 22:577-580, 1992. |
8605 |
sens |
|
| gi/upper |
9207 |
Gaspar, L. E., Qian, C., Kocha, W. I., Coia, L. R., Herskovic, A. and Graham, M.: A Phase I/II Study of External Beam Radiation, Brachytherapy and Concurrent Chemotherapy in Localized Cancer of the Esophagus (RTOG 92-07): Preliminary Toxicity Report. Proc Am Soc Thera Radiol Oncol (ASTRO), Miami Beach, FL, Int J Radiat Oncol Biol Phys, 32 (Supplement 1):160, [39], 1995. |
9207 |
chemo/brachy |
|
| gi/upper |
8501 |
Al-Sarraf, M., Martz, K., Herskovic, A., Leichman, L., Brindle, J., Vaitkevicius, V., Cooper, J., Byhardt, R., Davis, L. and Emami, B.: Superiority of Chemo-Radiotherapy (CT-RT) vs. Radiotherapy (RT) in Patients with Esophageal Cancer. Final Report of an Intergroup Randomized and Confirmed Study. Am Soc Clin Oncol (ASCO), Philadelphia, PA, Proc Am Soc Clin Oncol (ASCO), 15 (March 1996):206, [464], 1996. |
8501 |
chemo |
|
| gi/upper |
8501 |
Herskovic, A., Martz, K., Al-Sarraf, M., Leichman, L., Brindle, J., Vaitkevicius, V., Cooper, J., Byhardt, R., Davis, L. and Emami, B.: Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the Esophagus. New Engl J Med, 326(June 11):1593-1598, 1992. |
8501 |
chemo |
|
| gi/upper |
8501 |
Streeter Jr., O. E., Martz, K. L., Gaspar, L. E., DelRowe, J. D., Asbell, S. O. and Salter, M. E.: Does Race Influence Survival for Esophageal Cancers Treated on the Radiation and Chemotherapy Arm of RTOG 85-01? Proc Am Soc Thera Radiol Oncol (ASTRO), Miami Beach, FL, Int J Radiat Oncol Biol Phys, 32 (Supplement 1):268, [2012], 1995. |
8501 |
specpop |
|
| gi/upper |
|
Minsky, B. D., Neuberg, D., Kelsen, D. P., Pisansky, T. M., Ginsberg, R. and Benson III, A.: Neoadjuvant Chemotherapy Plus Concurrent Chemotherapy and High-Dose Radiation for Squamous Cell Carcinoma of the Esophagus: A Preliminary Analysis of the Phase II Intergroup Trial 0122. J Clin Oncol, 14(1):149-155, 1996. |
9012 |
chemo/surg |
|
| gi/upper |
8501 |
Herskovic, A., Pajak, T., Al-Sarraf, M., Leichman, L., Brindle, J., Vaitkevicius, V., Cooper, J., Byhardt, R., Davis, L. and Emami, B.: Significant Advantage of Chemo-Radiotherapy Compared to Radiation Alone in Randomized Phase III Trial for Patients with Esophageal Cancer: An Intergroup Study. Proc Am Soc Thera Radiol Oncol (ASTRO), Int J Radiat Oncol Biol Phys, 21 (1):190, [141], 1991. |
8501 |
chemo |
|
| gi/upper |
8501 |
Al-Sarraf, M., Pajak, T., Herskovic, A., Leichman, L., Brindle, J., Vaitkevicius, V., Cooper, J., Byhardt, R., Davis, L. and Emami, B.: Progress Report of Combined Chemo-Radiotherapy (CT-RT) vs. Radiotherapy (RT) Alone in Patients with Esophageal Cancer. An Intergroup Study. Proc Am Soc Clin Oncol (ASCO), Orlando, FL, Proceeding of ASCO (Twenty-ninth annual meeting), 12 (March 1993):197, [580], 1993. |
8501 |
chemo |
|
| gi/upper |
8501 |
Herskovic, A., Martz, K., Al-Sarraf, M., Leichman, L., Brindle, J., Vaitkevicius, V., Cooper, J., Byhardt, R., Davis, L. and Emami, B.: Intergroup Esophageal Study: Comparison of Radiotherapy (rt) to Radio-Chemotherapy Combination: A Phase III Trial. Proc Am Soc Clin Oncol (ASCO), 10 135, [407], 1991. |
8501 |
chemo |
|
| gi/upper |
|
Cox, J., Pajak, T., Marcial, V., Coia, L., Mohiuddin, M., Fu, K., Selim, H., Rubin, P. and Ortiz, H.: Interfraction Interval is a Major Determinant of Late Effects, with Hyperfractionated Radiation Therapy of Carcinomas of Upper Respiratory and Digestive Tracts: Results from Radiation Therapy Oncology Group Protocol 83-13. Int J Radiat Oncol Biol Phys, 20:1191-1195, 1991. |
8313 |
td/lateff |
|
| gi/upper |
|
Minsky, B., Neuberg, D., Kelsen, D., Pisansky, T., Ginsberg, R. and Benson, A. I.: Neoadjuvant Chemotherapy plus Concurrent Chemotherapy and High Dose Radiation for Squamous Cell Cancer of the Esophagus - A Preliminary Analysis of Intergroup Trial 0122 (ECOG PE-289/RTOG 90-12). Proc Am Soc Thera Radiol Oncol (ASTRO), Miami Beach, FL, Int J Radiat Oncol Biol Phys, 32 (Supplement 1):160, [38], 1995. |
9012 |
chemo |
|
|
|
